Dietary Supplements

Browse Dietary Supplements Content

These comments touch on several of the goals identified by ODS in the Progress Report.

Mar 6, 2015

CHPA appreciates the opportunity to provide the Office of Dietary Supplements (ODS) with comments on their Strategic Plan 2010-2014 Progress Report.

Mar 6, 2015

In general, the Part 111 GMP requirements, although similar, are less stringent and tend to be more flexible than the Part 211 GMP requirements.

Mar 4, 2015

Scientific experts familiar with herbal products and their testing methods maintain that the DNA barcode test is not an appropriate method to determine what is in an herbal dietary supplement.

Feb 23, 2015

CHPA applauds FDA's efforts to amend labeling regulations for conventional foods and dietary supplements in order to provide updated nutrition information to consumers.

Aug 1, 2014

Comments regarding guidance for clinical investigators, sponsors, and institutional review boards on investigational new drug applications - Determining whether human research studies can be conducted without an investigational new drug application.

Apr 7, 2014

There are several scientific and technical issues the agency should consider prior to issuing a final determination regarding partially hydrogenated oils (PHOs).

Mar 7, 2014

CRN and CHPA take this opportunity to share our views on the Food and Drug Administration’s Federal Register notice entitled, “Tentative Determination Regarding Partially Hydrogenated Oils; Request for Comments and for Scientific Data and Information.”

Mar 7, 2014

Filter Results